Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Wang, Shenqi ^a   Hou, Xuhong ^a   Liu, Yu ^a   Lu, Huijuan ^a   Wei, Li ^a   Bao, Yuqian ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Diabetes mellitus; Electrolytes; Impaired glucose regulation; Macrovascular complications; Normal glucose regulation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; CALCIUM; ELECTROLYTE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MAGNESIUM; METFORMIN; ORAL ANTIDIABETIC AGENT; POTASSIUM; SODIUM; SULFONYLUREA;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD ANALYSIS; CALCIUM BLOOD LEVEL; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; ELECTROLYTE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; SODIUM BLOOD LEVEL; VASCULAR DISEASE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANKLE BRACHIAL INDEX; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CALCIUM; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; DIABETIC ANGIOPATHIES; ELECTROLYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MAGNESIUM; MALE; MIDDLE AGED; POTASSIUM; PREVALENCE; RISK FACTORS; SODIUM;

EID: 84885160880     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-146     Document Type: Article

References (53)

1. Hall JE, Guyton AC. Textbook of medical physiology 2006, 228. St Louis, Mo: Elsevier Saunders.
2. Lobo DN. Fluid, electrolytes and nutrition: physiological and clinical aspects. Proc Nutr Soc 2004, 63(3):453-466. 10.1079/PNS2004376, 15373958.
3. DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976, 58(1):83-90. 10.1172/JCI108463, 333158, 932211.
4. Katz MA. Hyperglycemia-induced hyponatremia-calculation of expected serum sodium depression. N Engl J Med 1973, 289(16):843-844. 10.1056/NEJM197310182891607, 4763428.
5. Al-Rubeaan K, Siddiqui K, Abu Risheh K, Hamsirani R, Alzekri A, Alaseem A, Saleh SM, Al-Yami Z, Al-Ghamdi A, Alayed K. Correlation between serum electrolytes and fasting glucose and Hb1Ac in Saudi diabetic patients. Biol Trace Elem Res 2011, 144(1-3):463-468.
6. Levy J, Stern Z, Gutman A, Naparstek Y, Gavin JR, Avioli LV. Plasma calcium and phosphate levels in an adult noninsulin-dependent diabetic population. Calcif Tissue Int 1986, 39(5):316-318. 10.1007/BF02555197, 3102021.
7. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes res clin practice 2010, 87(2):261-266.
8. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007, 2(2):366-373. 10.2215/CJN.02960906, 17699436.
9. Padwal R, Laupacis A. Antihypertensive therapy and incidence of type 2 diabetes: a systematic review. Diabetes Care 2004, 27(1):247-255. 10.2337/diacare.27.1.247, 14693997.
10. Haglin L, Tornkvist B, Backman L. Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate,-calcium and-magnesium. Acta Diabetol 2007, 44(3):138-143. 10.1007/s00592-007-0254-6, 17721752.
11. Song Y, He K, Levitan E, Manson J, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabetic med 2006, 23(10):1050-1056. 10.1111/j.1464-5491.2006.01852.x, 16978367.
12. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009, 169(12):1437-1444. 10.1093/aje/kwp071, 2727202, 19372211.
13. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al. Prevalence of Diabetes among Men and Women in China. New England J Med 2010, 362(12):1090-1101.
14. Villegas R, Gao YT, Dai Q, Yang G, Cai H, Li H, Zheng W, Shu XO. Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai women's health study. Am J Clin Nutr 2009, 89(4):1059-1067. 10.3945/ajcn.2008.27182, 2667456, 19225116.
15. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, Lu HJ, Tang JL, Wu YM, Zuo YH, Jiang SY, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai diabetes studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007, 50(2):286-292. 10.1007/s00125-006-0503-1, 17180353.
16. Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010, 340:c2249. 10.1136/bmj.c2249, 2871988, 20478961.
17. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266. National Kidney Foundation.
18. For a complete listing of the members of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157(21):2413-2446. For a complete listing of the members of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee.
19. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113(11):e463-e654.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, 9686693.
21. Chalmers J. The 1999 WHO-ISH guidelines for the management of hypertension. Med J Aust 1999, 171(9):458-459.
22. Expert Panel on Metabolic Syndrome of Chinese Diabetes Society Recommendations on metabolic syndrome of chinese diabetes society (Chinese). Chin J Diab 2004, 12:156-161. Expert Panel on Metabolic Syndrome of Chinese Diabetes Society.
23. Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China national diabetes and metabolic disorders study. Eur Heart J 2012, 33(2):213-220. 10.1093/eurheartj/ehr205, 21719451.
24. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99(10):1044-1059. 10.1161/01.RES.0000249379.55535.21, 17095733.
25. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American diabetes association. Diabetes Care 2006, 29(12):2739-2748. 10.2337/dc06-9916, 17130218.
26. McNair P, Madsbad S, Christiansen C, Christensen MS, Transbol I. Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. Clin Chim Acta 1982, 120(2):243-250. 10.1016/0009-8981(82)90161-9, 7039873.
27. Haglin L, Backman L, Tornkvist B. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol 2011, 10:116. 10.1186/1475-2840-10-116, 3265426, 22192330.
28. Roscoe J, Halperin M, Rolleston F, Goldstein M. Hyperglycemia-induced hyponatremia: metabolic considerations in calculation of serum sodium depression. Can Med Assoc J 1975, 112(4):452. 1956157, 1111894.
29. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am j med 1999, 106(4):399-403. 10.1016/S0002-9343(99)00055-8, 10225241.
30. Yajnik C, Smith R, Hockaday T, Ward N. Fasting plasma magnesium concentrations and glucose disposal in diabetes. British med j (Clin res ed) 1984, 288(6423):1032-1034.
31. Guyton A, Hall J. Textbook of medical physiology 2006, 348-381. Philadelphia, PA: Elsevier Saunders.
32. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999, 10(12):2569-2576.
33. Yamaguchi T, Kanazawa I, Takaoka S, Sugimoto T. Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metabolism 2011, 60(9):1334-1339. 10.1016/j.metabol.2011.02.003, 21489574.
34. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 2005, 54(11):3336-3339. 10.2337/diabetes.54.11.3336, 16249463.
35. Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999, 10(7):1616-1622.
36. Frost M, Abrahamsen B, Nielsen TL, Hagen C, Andersen M, Brixen K. Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism. Clin Endocrinol (Oxf) 2010, 73(5):573-580.
37. Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther 2007, 14(4):375-385. 10.1097/01.mjt.0000209676.91582.46, 17667214.
38. Bjornholm M, Zierath JR. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans 2005, 33(Pt 2):354-357.
39. Shahid SM, Rafique R, Mahboob T. Electrolytes and sodium transport mechanism in diabetes mellitus. Pak J Pharm Sci 2005, 18(2):6-10.
40. Mikaelian NP, Gurina AE, Terent'ev AA. Dysfunction of membrane-receptor system of blood cells and kidney tissue in experimental diabetes mellitus. Bull Exp Biol Med 2013, 154(5):610-613. 10.1007/s10517-013-2011-x, 23658880.
41. Dhalla NS, Rangi S, Zieroth S, Xu YJ. Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy. Exp Clin Cardiol 2012, 17(3):115-120. 3628423, 23620698.
42. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995, 48(7):927-940. 10.1016/0895-4356(94)00200-A, 7782801.
43. Larsson SC, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012, 95(2):362-366. 10.3945/ajcn.111.022376, 22205313.
44. Rodriguez-Moran M, Guerrero-Romero F. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Arch Med Res 2001, 32(4):300-303. 10.1016/S0188-4409(01)00298-3, 11440788.
45. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990, 33(9):511-514. 10.1007/BF00404136, 2253826.
46. Hashimoto T, Hara A, Ohkubo T, Kikuya M, Shintani Y, Metoki H, Inoue R, Asayama K, Kanno A, Nakashita M, et al. Serum magnesium, ambulatory blood pressure, and carotid artery alteration: the Ohasama study. Am J Hypertens 2010, 23(12):1292-1298. 10.1038/ajh.2010.168, 20706194.
47. Maier JA, Malpuech-Brugere C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004, 1689(1):13-21. 10.1016/j.bbadis.2004.01.002, 15158909.
48. Adhikari S, Toretsky JA, Yuan L, Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase. J Biol Chem 2006, 281(40):29525-29532. 10.1074/jbc.M602673200, 16901897.
49. Barbagallo M, Dominguez LJ. Magnesium intake in the pathophysiology and treatment of the cardiometabolic syndrome: where are we in 2006?. J Cardiometab Syndr 2006, 1(5):356-357. 10.1111/j.1559-4564.2006.06104.x, 17679797.
50. Martini LA, Catania AS, Ferreira SR. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev 2010, 68(6):341-354. 10.1111/j.1753-4887.2010.00296.x, 20536779.
51. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Sarfaraz RA, Shah A, Kandhro GA, Shah AQ, et al. Potassium, calcium, magnesium, and sodium levels in biological samples of hypertensive and nonhypertensive diabetes mellitus patients. Biol Trace Elem Res 2008, 124(3):206-224. 10.1007/s12011-008-8142-7, 18488152.
52. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993, 36(8):767-770. 10.1007/BF00401149, 8405745.
53. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004, 57(10):1096-1103. 10.1016/j.jclinepi.2004.04.005, 15528061.